Histopathological and biological prognostic risk factors in low stage testicular nonseminomatous germ cell tumors
| 详细信息 | 推荐本文 | |
- 作者：A. Heidenreich ; I. A. Sesterhenn ; F. K. Mostofi ; J. W. Moul and U. H. Engelmann
- 关键词：Key words Nonseminomatous germ cell tumor • ; Prognosis • ; Vascular invasion • ; Embryonal carcinoma • ; p53 • ; bcl ; 2 • ; Cathepsin D • ; E ; cadherin
- 刊名：Der Urologe A
- 出版时间：March1999
- 出版年：1999
- 期刊代码：212_0340-2592
- 类别：med
- 卷：38
- 期：2
- 页码：168-178
- 数据来源：sp
摘要
Purpose of our study was to develop a reliable model to define clinical stage I nonseminomatous germ cell tumors (NSGCT) being at low risk and at high risk for occult retroperitoneal metastases based on pathohistological and immunohistochemical parameters in order to stratify the therapeutic approach. 3–5 paraffin-embedded formalin fixed tissue blocks of 149 clinical stage I NSGCT were available from all patients and were analyzed for histopathological features associated with pathological stage: presence/absence of vascular invasion, presence/absence of tunical invasion, percentage of each histological cell type present in the primary tumor. Immunohistochemical expression of MIB-1, p53, bcl-2, cathepsin D and e-cadherin was evaluated using a semiquantitative scoring ystem. Statistical analysis was performed by univariate and multivariate logistic regression models. Percentage of embryonal carcinoma [%EC (p < 0.001)] and presence of vascular invasion [VI (p < 0.0001)] were the most significant independent risk factors associated with pathological stage II disease. Combination of%EC and VI allowed correct prediction of final pathological stage in 88%of patients. Cut-off values including both variables identified correct pathological stage in 131/149 patients (88%). Less than 45%EC and absence of VI correctly identified pathological stage I disease in 91.5%; more than 80%EC and presence of VI correctly predicted pathological stage II in 88%of the patients.%EC and presence/absence of VI appear to be reliable prognosticators to identify both patients at high risk and at low risk for occult retroperitoneal disease. P53, bcl-2, MIB-1, cathepsin D and e-cadherin did not appear to be of prognostic value in clinical stage I NSGCT.